TrilliumBiO Information

TrilliumBiO is a translational diagnostics company transforming how biomarkers are integrated into patient care. The company’s unified platform spans discovery, validation, and commercialization to deliver clinically actionable diagnostics. These solutions identify at-risk patients, monitor disease, and guide emerging therapies supporting a more personalized, data-driven model of care. With a scalable, high-performing laboratory infrastructure, TrilliumBiO offers a portfolio of specialized, clinically tailored assays. Its partnership-driven model enables the rapid development and deployment of diagnostics in complex and underserved disease areas. Headquartered in Maryland, just outside Washington, D.C., TrilliumBiO operates within the nation’s third-largest biopharma hub.